Update on hepatitis E virology: Implications for clinical practice.
about
Role of Envelopment in the HEV Life CycleHepatitis E Virus Mutations: Functional and Clinical RelevanceAcute Hepatitis E: Two Sides of the Same CoinMutagenic Effects of Ribavirin on Hepatitis E Virus-Viral Extinction versus Selection of Fitness-Enhancing MutationsReview article: hepatitis E-a concise review of virology, epidemiology, clinical presentation and therapy.Hepatitis E Virus Genotypes and Evolution: Emergence of Camel Hepatitis E VariantsPrevalence and Molecular Characterization of the Hepatitis E Virus in Retail Pork Products Marketed in Canada.Production of monoclonal antibodies against the ORF3 protein of rat hepatitis E virus (HEV) and demonstration of the incorporation of the ORF3 protein into enveloped rat HEV particles.Incidence and Molecular Characterization of Hepatitis E Virus from Swine in Eastern Cape, South Africa.The hepatitis E virus nonstructural polyprotein.Hepatitis A to E: what's new?The Enigma of Hepatitis E Virus.Hepatitis E virus as a cause of acute hepatitis acquired in Switzerland.ORF3 as a sensitive and specific diagnostic index for hepatitis E.RIG-I is a key antiviral interferon-stimulated gene against hepatitis E virus regardless of interferon production.Excretion of infectious hepatitis E virus into milk in cows imposes high risks of zoonosis.Current status and strategies for viral hepatitis control in Korea.New Hepatitis E Virus Genotype in Bactrian Camels, Xinjiang, China, 2013.Identification of GBF1 as a cellular factor required for hepatitis E virus RNA replication.Acute hepatitis E virus infection causing acute liver failure requiring living-donor liver transplantation in a non-pregnant immunocompetent woman.Knowledge gaps and research priorities in the prevention and control of hepatitis E virus infection.High seroprevalence of hepatitis E virus in the ethnic minority populations in Yunnan, China.HEV ORF3 downregulates TLR7 to inhibit the generation of type I interferon via impairment of multiple signaling pathways.Hepatitis E in High-Income Countries: What Do We Know? And What Are the Knowledge Gaps?
P2860
Q26739943-79100BCB-BA6F-44B2-A288-C85E16C00F08Q26741356-C2B6F9F3-BDB0-4967-ADB9-C2FA89E2C4F2Q28069291-C42C83AF-2447-4227-9F9E-21A78A3FDE96Q28072953-F9C6DA12-F85A-4576-9B90-8085451E36ABQ30234629-1FE83FC8-A133-4739-A2EA-3B2D33B999D7Q30234734-E0181577-789E-48CD-867C-708FF5558CBAQ33676698-2D7A5A26-6B8B-41C0-A0BA-AAEA4335770BQ36136176-6155E5B9-F587-4A39-ABD1-2079372ACEA5Q37612037-AF1B1D3F-2DA6-402E-8C8E-2A716E79C1CEQ38661359-5DE05A82-2295-4BAB-A6F6-8A34E5264217Q39237214-44BBF68A-9E09-4018-AED2-91CE8CF5BE04Q40059581-1E7CDD8C-639C-43F0-9D90-CC032C73DC7CQ40073557-32C5495C-60F1-44B0-9459-9AA3C38A3CC7Q40170633-5FF6BF4E-43FF-4369-B69F-A203EAA1EA3EQ40333877-E097D401-7F01-4D3A-8564-A1BA21A24376Q40707887-EA7C1349-6330-4D05-8C53-87F1E0352D70Q41931211-5752037C-1F39-468D-AF02-F517536D0316Q42341080-6CA5E680-C837-497A-9BB6-6AAF868195BFQ45325189-3564299B-7AE6-4EA1-B192-A3D4C2BBE8EEQ45329959-98650A42-495E-4AF7-98D6-9B4A9CEC15BBQ47556196-B2FE5855-B734-4A47-BCEC-B7489BBD4681Q54202936-6E34A606-10F3-471F-9838-547DC6B8E4CEQ55286527-31879E5B-AD12-4FD2-8916-4231ED380381Q56000615-89CD5ABD-B7C3-4E62-9B34-1455005ABB92
P2860
Update on hepatitis E virology: Implications for clinical practice.
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Update on hepatitis E virology: Implications for clinical practice.
@ast
Update on hepatitis E virology: Implications for clinical practice.
@en
type
label
Update on hepatitis E virology: Implications for clinical practice.
@ast
Update on hepatitis E virology: Implications for clinical practice.
@en
prefLabel
Update on hepatitis E virology: Implications for clinical practice.
@ast
Update on hepatitis E virology: Implications for clinical practice.
@en
P50
P1476
Update on hepatitis E virology: Implications for clinical practice.
@en
P2093
Yannick Debing
P304
P356
10.1016/J.JHEP.2016.02.045
P577
2016-03-07T00:00:00Z